Jongsun Jung

Title: Jongsun Jung: Innovator in AI-Driven Biomarker Discovery

Introduction

Jongsun Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of artificial intelligence and genomics, holding a total of 2 patents. His work focuses on developing innovative methods for biomarker discovery and human haplotyping.

Latest Patents

One of Jongsun Jung's latest patents is titled "Hilbert-CNN: AI-Driven Convolutional Neural Networks with Conversion Data of Genome for Biomarker Discovery." This patent describes a method for detecting biomarkers using an AI deep learning model that processes conversion data of nucleotide sequences and population genome mutations. The method involves collecting nucleotide sequences, generating conversion data, and utilizing an AI model to extract biomarkers through a fully connected network.

Another significant patent is the "Human Haplotyping System and Method." This invention outlines a method for analyzing gene sequences by matching and aligning reads to a reference database. It includes steps for electing candidate alleles and selecting a final allele from the candidates, enhancing the accuracy of genetic analysis.

Career Highlights

Jongsun Jung has worked with notable companies in the biotechnology sector, including Syntekabio, Inc. and Syntekabio Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in genomic research.

Collaborations

Jongsun has collaborated with talented individuals such as Jaeyun Yoo and Jaemin Seol. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies in the field of genomics.

Conclusion

Jongsun Jung is a visionary inventor whose work in AI and genomics is paving the way for future advancements in biomarker discovery and genetic analysis. His contributions are significant in the ongoing evolution of biotechnology.